Roche Holding AG received emergency-use authorization from the U.S. Food and Drug Administration for its new Covid-19 antibody test, according to a company statement. Governments are trying to learn how many people have been exposed to Covid-19 as they reopen economies and end social-distancing measures. The restrictions have resulted in millions of lost jobs, closed …
Continue reading “US FDA approves Roche’s coronavirus antibody test”
Government clinical trial investigators changed the primary metric for measuring the success of Gilead’s experimental drug remdesivir as a coronavirus treatment two weeks before Anthony S. Fauci’s announcement that the drug would be the new “standard of care.” Instead of counting how many people taking the drug were kept alive on ventilators or died, among …
Berkshire Hathaway announced on Saturday its GAAP net loss in the first quarter of 2020 amounted to $49.75 billion or $30,653 per Class A share. However, operating income, which Berkshire chief executive Waren Buffet considers a better performance measure, rose 6% on a yearly basis to $5.87 billion. Asset value dropped 7% quarter-on-quarter to $760 …
Continue reading “Berkshire Hathaway posts Q1 net loss at $49.8B”
Bombshell ‘Five Eyes’ Western intelligence dossier claims China lied about human-to-human transmission, ‘disappeared’ whistle-blowers and refused to help other countries prepare a vaccine for coronavirus Chinas ‘risky’ research on bat-related diseases stretching back years. It describes how Beijing was outwardly downplaying the outbreak on the world stage while secretly scrambling to bury all traces …
Continue reading “Leaked dossier details China hiding virus info”
The Food and Drug Administration will authorize Gilead Sciences Inc.’s remdesivir, a decade-old experimental therapy first tested on Ebola disease patients, as a COVID-19 treatment. Gilead CEO Daniel O’Day told investors during an earnings call that talks with the FDA about an emergency use authorization (EUA) or a formal approval have intensified over the last …
Continue reading “Trump: Gilead drug got emergency use green light from FDA”
U.S. incomes fell in March but not as much as spending, pushing the savings rate to its highest level in 39 years, the government said Thursday. Income fell 2% in March, with an identical decline in disposable income. At the same time, spending slumped a record 7.5% last month. The spending data was not a …
Continue reading “U.S. savings rate jumps to highest level in 39 years”
(CNN)As he huddled with advisers on Friday evening, President Donald Trump was still fuming over his sliding poll numbers and the onslaught of criticism he was facing for suggesting a day earlier that ingesting disinfectant might prove effective against coronavirus. Within moments, the President was shouting — not at the aides in the room, but …
Continue reading “Trump erupts at campaign manager as reelection stress overflows”
Every major American art museum is sitting on assets that, from the outside, look enviable. They’re called works of art. If they’re by Vincent van Gogh or Frida Kahlo or Jackson Pollock, they may be worth tens, or even hundreds, of millions of dollars. Even if they’re by less famous artists and consigned to storage …
Wholesale American beef prices jumped 6% to a record high of $330.82 per 100 pounds, a 62% increase from the lows in February, according to Bloomberg, citing new USDA data. The surge in beef prices comes at a time when the nation’s food supply chain network has been severely damaged by meatpacking plants going offline due …
Continue reading “Beef Prices Soar To Record High As Meatpacking Plants Shutter”
SINGAPORE (Bloomberg) –Oil jumped for a second day as global production cuts deepened and signs of a fledgling demand recovery emerged. Futures in New York rose by as much as 18%. Norway said it will participate in oil-output cuts for the first time since 2002, joining other major producers in reining in supply. Data on …
Continue reading “Oil continues climb on signs of a coming demand recovery”